Skip to content

PASCAL Feasibility Study

Feasibility of Using a Conversational Agent for Promoting Smoking Cessation Treatment Utilization

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07301151
Enrollment
120
Registered
2025-12-24
Start date
2026-05-01
Completion date
2027-06-30
Last updated
2026-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation, Smoking (Tobacco) Addiction

Keywords

cigarette smoking, chatbot

Brief summary

The goal of this randomized study is to assess if a conversational agent (or chatbot) that the investigators have developed to help with quitting smoking is acceptable to people trying to quit smoking and to also collect initial information regarding its effectiveness. In this study, some participants trying to quit smoking will be provided with this chatbot while other participants will not be

Interventions

OTHERchatbot

a chatbot will alert during predicted high risk smoking times and suggest approaches to manage potential smoking triggers

OTHERno chatbot

no chatbot is provided

Sponsors

University of Minnesota
Lead SponsorOTHER
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Identify as Black or African American * Be at least 21 years of age * Meet a minimum smoking amount * Be willing to make a quit attempt in the next 30 days * Have a smartphone capable of downloading and running the study app * Be able to upload data from the app * Agree to receive text message reminders about study activities * Be a native English speaker * Reside in Minnesota.

Exclusion criteria

* Medicinal nicotine use would require careful monitoring by a healthcare professional * Medical condition or medication used likely to significantly interfere with study outcomes or to be significantly affected by changes in smoking behavior * Are pregnant or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of trial procedures1 dayThe proportion of enrolled participants who download the study app
Feasibility of study procedures2 weeksThe proportion of participants (among those who downloaded the app) who complete the week 2 post-quit visit
Health Information Technology Usability Evaluation Scale (Health-ITUES)2 weeksThis scale will be used to access the acceptability of study app. The scale consists of 20 questions scored from 1 to 5 with higher values indicating more positive response

Secondary

MeasureTime frameDescription
Average number of daily interactions with the study app2 weeks
The average number of cigarettes smoked per day2 weeks
Average number of nicotine lozenges used2 weeks
The proportion of participants who complete the week 8 post-quit visit8 weeks
The proportion of participants not smoking for the 7 day period before the week 2 visit2 weeks
The proportion of participants not smoking for the 7 day period before the week 8 visits8 weeks
The proportion of participants not smoking at all between the quit date and the week 2 visit2 weeks
The proportion of participants not smoking at all between the quit date and the week 8 visit8 weeks
Motivation to quit smoking2 weeksUsing a 1 - 10 scale on the contemplation to quit ladder (1 - no interest in quitting; 10 - will never smoke again)
Brief Questionnaire of Smoking Urges (QSU-Brief)2 weeksQuestionnaire assessing craving severity. Range for total score is 10 - 70 with higher score indicating greater craving
The Minnesota Nicotine Withdrawal Scale (MNWS)2 weeksQuestionnaire assessing withdrawal symptom severity. Range for total score is 0 - 36 with higher score indicating greater withdrawal symptoms

Countries

United States

Contacts

CONTACTSheena Study Coordinator
gahmx008@umn.edu612-626-5981
PRINCIPAL_INVESTIGATORMichael Kotlyar

University of Minnesota

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026